Treatment of a patient with remitting seronegative, symmetrical synovitis with pitting oedema with a humanized anti-interleukin-6 receptor antibody, tocilizumab

被引：18
|
作者：
Tanaka, Toshio [1 ]
Hagihara, Keisuke [1 ]
Shima, Yoshihito [1 ]
Narazaki, Masashi [1 ]
Ogata, Atsushi [1 ]
Kawase, Ichiro [1 ]
Kishimoto, Tadamitsu [2 ]
机构：
[1] Osaka Univ, Grad Sch Med, Dept Resp Med Allergy & Rheumat Dis, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Grad Sch Frontier Biosci, Lab Immune Regulat, Suita, Osaka 5650871, Japan
来源：
RHEUMATOLOGY | 2010年 / 49卷 / 04期
关键词：
RS3PE SYNDROME;
D O I：
10.1093/rheumatology/kep412
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：824 / 826
页数：4
相关论文
共 50 条
  • [1] Anti-interleukin-6 receptor antibody for the treatment of remitting seronegative symmetrical synovitis with pitting oedema: a new outlook?
    de Sousa, Rita Noversa
    Rocha, Diana Marques
    Simoes, Marisa Nair
    Rosario, Cristina
    BMJ CASE REPORTS, 2024, 17 (03)
  • [2] Tocilizumab, a humanized anti-interleukin-6 receptor antibody, for treatment of rheumatoid arthritis
    Mihara, Masahiko
    Ohsugi, Yoshiyuki
    Kishimoto, Tadamitsu
    OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2011, 3 : 19 - 29
  • [3] Tocilizumab, a humanized anti-interleukin-6 receptor antibody, for the treatment of autoimmune disorders
    Tanaka, Toshio
    Hagihara, Keisuke
    Shima, Yoshihito
    Narazaki, Masashi
    Ogata, Atsushi
    Kumanogoh, Atsushi
    DRUG DEVELOPMENT RESEARCH, 2011, 72 (08) : 717 - 732
  • [4] Remitting seronegative symmetrical synovitis with pitting oedema associated with rifampicin
    D. Smyth
    R. Rehman
    K. Remund
    J. Egan
    Irish Journal of Medical Science, 2011, 180 : 585 - 586
  • [5] Remitting seronegative symmetrical synovitis with pitting oedema associated with rifampicin
    Smyth, D.
    Rehman, R.
    Remund, K.
    Egan, J.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2011, 180 (02) : 585 - 586
  • [6] Successful Treatment of Reactive Arthritis With a Humanized Anti-Interleukin-6 Receptor Antibody, Tocilizumab
    Tanaka, Toshio
    Kuwahara, Yusuke
    Shima, Yoshihito
    Hirano, Toru
    Kawai, Mari
    Ogawa, Masako
    Arimitsu, Junsuke
    Hagihara, Keisuke
    Narazaki, Masashi
    Ogata, Atsushi
    Kawase, Ichiro
    Kishimoto, Tadamitsu
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (12): : 1762 - 1764
  • [7] Remitting seronegative symmetrical synovitis with pitting oedema in a patient with myelodysplastic syndrome and relapsing polychondritis
    Manganelli, P
    Delsante, G
    Bianchi, G
    Fietta, P
    Quaini, F
    CLINICAL RHEUMATOLOGY, 2001, 20 (02) : 132 - 135
  • [8] Remitting Seronegative Symmetrical Synovitis with Pitting Oedema in a Patient with Myelodysplastic Syndrome and Relapsing Polychondritis
    P. Manganelli
    G. Delsante
    G. Bianchi
    P. Fietta
    F. Quaini
    Clinical Rheumatology, 2001, 20 : 132 - 135
  • [9] Remitting seronegative symmetrical synovitis pitting oedema after BCG instillation
    Soumaya El Mahou
    Luciana Popa
    Arnaud Constantin
    Alain Cantagrel
    Achour Aberrane
    Benedicte Jamard
    Bernard Mazieres
    Michel Laroche
    Clinical Rheumatology, 2006, 25 : 566 - 567
  • [10] Remitting seronegative symmetrical synovitis with pitting oedema associated with lung malignancy
    Mattace-Raso, Francesco U. S.
    van der Cammen, Tischa J. M.
    AGE AND AGEING, 2007, 36 (04) : 470 - 471
12345